Skip to main content
. 2002 Oct;15(4):545–563. doi: 10.1128/CMR.15.4.545-563.2002

TABLE 4.

Treatment of AD patients with antifungal drugs

Study Treatment Design Results
Clemensen and Hjorth 1983, (26) Oral ketoconazole Double-blind crossover Ketoconazole > placebo
Back et al., 1995 (8) Oral ketoconazole Open Ketoconazole > placebo
Morita et al., 1999 (106) Oral ketoconazole or fluconazole Open Ketoconazole = fluconazole
Back et al., 2001 (9) Oral ketoconazole Double blind Ketoconazole = placebo
Lintu et al., 2001 (101) Oral ketoconazole Double blind Ketoconazole > placebo
White et al., 1983 (158) Topical hydrocortisone + miconazole Open Active > placebo
Broberg et al., 1995 (20) Topical hydrocortisone + miconazole Double blind Active = placebo